Today: 11 June 2026
DroneShield stock closes higher after new-share filing; what ASX:DRO investors watch next
13 January 2026
1 min read

DroneShield stock closes higher after new-share filing; what ASX:DRO investors watch next

Sydney, Jan 13, 2026, 17:25 AEDT — Market closed.

  • DroneShield shares closed up following an ASX filing that revealed 500,000 new shares issued from performance options
  • New stock issued for nil cash, boosting total ordinary shares outstanding
  • Attention now turns to late-February results timing and potential new order updates

DroneShield Ltd has applied to list 500,000 new ordinary shares stemming from performance option exercises, according to an ASX filing. The shares were issued without any cash consideration, pushing the total ordinary shares on issue to 913,917,667. The stock closed 1.3% higher at A$3.90 on Tuesday.

It’s a modest uptick percentage-wise, yet it strikes a familiar chord. In a stock sensitive to supply, even standard filings can sway trading, particularly since this change doesn’t inject new cash into the company.

The market may be closed now, but the real test comes in the next session. Traders will watch closely to see if the added shares stay put in long-term portfolios or trigger short-term selling. They’ll also be tracking any further option conversions.

The S&P/ASX 200 climbed 0.56% to close at 8,808.5 on Tuesday, following widespread advances in the market.

DroneShield specializes in radio-frequency sensing and electronic warfare systems aimed at detecting and disabling drones — known in defense circles as “counter-UAS,” or counter-uncrewed aerial systems. Its lineup features products like DroneGun and DroneSentry, among others. Reuters

The filing resembles housekeeping more than fundraising and leaves the company’s cash untouched. However, it does increase the share count that investors rely on for per-share metrics and valuations.

The downside is clear: a pay pipeline tied to stock can continuously flood the market with new shares, while defence procurement often happens in fits and starts. If contract schedules slip or clients delay deliveries, the share price can quickly take a hit.

Investors are eyeing the next key trigger: DroneShield is set to release preliminary and annual results on Feb. 24, per Market Index’s calendar. This update should shed light on orders, deliveries, and cash flow.

Stock Market Today

  • Paramount-Warner Bros. Merger Faces Regulatory Cost Risks
    June 11, 2026, 2:49 PM EDT. The planned merger between Paramount Skydance and Warner Bros. Discovery has encountered opposition in Hollywood, but the more significant risk lies in potential increased costs. Regulatory scrutiny could delay the deal, leading to additional expenses for Paramount. Such delays often arise from antitrust reviews aimed at preventing reduced competition. This regulatory environment poses a financial threat that could weigh on the merger's feasibility and market reactions.

Latest articles

MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

MARA Stock Edges Higher After Bitcoin Holds Steady, Q1 Miss and AI Uncertainty in Focus

11 June 2026
MARA surged 5.2% to $13.27 as bitcoin rebounded to $63,375, drawing investor focus after a sharp prior-session drop, even as Q1 net loss widened to $1.26 billion on lower revenue and bitcoin sales; the stock’s move reflects renewed risk appetite amid ongoing concerns over financial performance and the company’s pivot toward AI and data center infrastructure.
Alphabet shares edge lower while Google considers new AI chip suppliers

Alphabet shares edge lower while Google considers new AI chip suppliers

11 June 2026
Alphabet shares fell about 1% to $352.50 Thursday, underperforming a market rebound, as investors weighed reports that Google is in talks with Samsung to manufacture part of a next-generation AI chip, with the communication-services sector lagging and chipmakers rebounding after a prior selloff.
Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal
Previous Story

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop